Therapeutic Options for Establised or Recurrent Atrial Fibrillation: Focus on Antithrombotic Therapy

  • John H. McAnulty
  • Jack Kron
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 222)


A stroke at any time may be devastating, This is just as true after heart surgery. Recognized perioperative cerebrovascular accidents, with a permanent deficit, occur in approximately three percent of patients undergoing coronary artery bypass graft surgery. Another three percent develop seizures or deterioration of neurologic function [1-3] (Table 1). Following valve surgery, the rates of embolic events are slightly higher (with over 90% of the emboli involving the brain) [4-7] (Table 1). Emboli from manipulation of atherosclerotic aortas probably explain a majority of these neurologic events; [3] some may be due to thromboemboli.


Atrial Fibrillation Stroke Prevention Coronary Artery Bypass Graft Surgery Atrial Fibrillation Patient Antithrombotic Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 1996;94:390–397.PubMedGoogle Scholar
  2. 2.
    Newman, MF, Wolman R, Kanchuger M, Marschall K, Mora-Mangano C. Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. American Heart Association, Inc. 1996; II-74–II-80.Google Scholar
  3. 3.
    Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, et al. Adverse cerebral outcomes after coronary bypass surgery. N Eng J Med 1996;335:1857–1863.CrossRefGoogle Scholar
  4. 4.
    Heras M, Chesebro JH, Fuster V, Penny W, Grill D. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. JACC 1995;11:1111–1119.Google Scholar
  5. 5.
    Davis EA, Greene PS, Cameron DE, Gott VL, Laschinger JC. Bioprosthetic versus mechanical prostheses for aortic valve replacement in the elderly. Circulation 1996;94:II-121–II-125.Google Scholar
  6. 6.
    Borger MA, Ivanov J, Weisel RD, Peniston CM, Mickleborough LL. Decreasing incidence of stroke during valvular surgery. Circulation 1998; II-137–II-143.Google Scholar
  7. 7.
    Moinudden K, Quin J, Shaw R, Dewar M, Tellides G. Anticoagulation is unnecessary after biological aortic valve replacement. Circulation 1998; II-95–II-99.Google Scholar
  8. 8.
    Mathew JP, Parks R, Savino JS, Friedman AS, Koch C, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. JAMA 1996;276:1719–1720.CrossRefGoogle Scholar
  9. 9.
    Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989;31:367–378.CrossRefPubMedGoogle Scholar
  10. 10.
    Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. New Eng J Med 1997;337:1785–1791.CrossRefPubMedGoogle Scholar
  11. 11.
    Stroke Prevention in Atrial Fibrillation Investigators. SPAF Study final results. Circulation 1991;84:527–539.Google Scholar
  12. 12.
    Petersen P, Boysen G, Godtfredsen J, Andersen E, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen study. Lancet 1989;1:175–178.CrossRefPubMedGoogle Scholar
  13. 13.
    The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505.CrossRefGoogle Scholar
  14. 14.
    Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators: Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Eng J Med 1992;327:1406–12.CrossRefGoogle Scholar
  15. 15.
    Connolly SJ, Laupacis A, Gent M, et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349.CrossRefPubMedGoogle Scholar
  16. 16.
    Stoke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation:I. Clinical features of patients at risk. Ann Intern med 1992;116:1–5.Google Scholar
  17. 17.
    Stroke Prevention in Atrial Fibrillation Investigators. Warfarin vs. aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in atrial Fibrillation II Study. Lancet 1994;343:687–691.Google Scholar
  18. 18.
    Atrial Fibrillaton Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized clinical trials. Arch Int med 1994;54:1949–1957.Google Scholar
  19. 19.
    Stroke Prevention in Atrial Fibrillation Investigators. Prospective identification of patients with nonvalvular atrial fibrillation at low-risk of stroke during treatment with aspirin. JAMA 1998;279:1273–77.CrossRefGoogle Scholar
  20. 20.
    Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin vs. low-intensidy, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in Atrial Fibrillation III Study. Lancet 1996;348:633–638.CrossRefGoogle Scholar
  21. 21.
    McAnulty JH, Rahimtoola SH. Antithrombotic therapy and valvular heart disease. In Hurst’s The Heart, 9 th Edition, Alexander R, Schlant R, Fuster V, ed.: McGraw-Hill Companies, Inc. 1998.Google Scholar
  22. 22.
    Stroke Prevention in Atrial Ribrillation Investigators. Predictors of thromboembolism in atrial fibrillation:II. Echocardiographic features of patients at risk. Annals Int med 1992;116:6–12.Google Scholar
  23. 23.
    Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardio 1998;31:1622–6.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • John H. McAnulty
    • 1
  • Jack Kron
    • 1
  1. 1.Oregon Health Sciences UniversityPortland

Personalised recommendations